Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Number of Launched Drugs:0 Number of Drugs in Clinical Trials:1 Lastest Research Phase:Phase 1 Clinical
Product Inquiry
* We couldn't find what you're looking for. You can let us help by filling the form below. Our
tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information
will be kept strictly confidential.
Synonym Name
TDGF1,CRGF,CRIPTO
Background
Teratocarcinoma-derived growth factor 1 (TDGF1) is also known as Cripto-1 growth factor (CRGF), Epidermal growth factor-like cripto protein CR1, CRIPTO, is a cell membrane which contains one EGF-like domain. TDGF1 is preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts. TDGF1 interacts with the activin type-1 receptor ACVR1B. TDGF1 could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.